瘤囊栓塞与分支栓塞预防EVAR术后II型内漏的Meta分析
该Meta分析纳入17项研究共2084例EVAR患者,评估术前分支栓塞或术中瘤囊栓塞预防II型内漏的疗效与安全性。结果显示瘤囊栓塞和分支栓塞均显著降低II型内漏及再干预率,且未增加I/III型内漏或并发症风险,分支栓塞组报告1例致死性结肠缺血。
要点
- 瘤囊栓塞显著降低EVAR术后II型内漏(OR 0.21)和再干预率(OR 0.15)。
- 分支栓塞同样降低II型内漏(OR 0.35)和再干预率(OR 0.10)。
- 两种栓塞均未增加I/III型内漏或并发症风险,但分支栓塞有1例致死性结肠缺血。
核心结论
- 瘤囊栓塞和分支栓塞均可安全有效地预防EVAR术后II型内漏。
- 仍需随机试验直接比较两种栓塞方式的临床结局。
研究设计与样本
- 系统检索MEDLINE和EMBASE,筛选904项研究,最终纳入17项研究共2084例接受EVAR的患者。
- 比较瘤囊栓塞 vs 无栓塞或分支栓塞 vs 无栓塞,采用固定或随机效应模型,结果以OR及95%CI表示。
主要发现
- 瘤囊栓塞组II型内漏率显著低于无栓塞组(OR 0.21,95%CI 0.13至0.34,p<0.001)。
- 瘤囊栓塞组再干预率显著低于无栓塞组(OR 0.15,95%CI 0.07至0.33,p<0.001)。
- 瘤囊栓塞组与无栓塞组在I/III型内漏率(OR 0.57,95%CI 0.23至1.37,p=0.21)和并发症率(OR 1.22,95%CI 0.32至4.70,p=0.77)上无显著差异。
- 分支栓塞组II型内漏率(OR 0.35,95%CI 0.21至0.60,p<0.001)和再干预率(OR 0.10,95%CI 0.04至0.27,p<0.001)均显著低于无栓塞组。
- 分支栓塞组报告1例严重操作相关并发症(致死性结肠缺血)。
临床怎么用
- 对于II型内漏高风险EVAR患者,可考虑瘤囊栓塞或分支栓塞以降低内漏及再干预风险。
- 分支栓塞需警惕罕见但严重的结肠缺血并发症。
局限性
- 纳入研究以观察性研究为主,需进一步随机试验直接比较两种栓塞方式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Purpose:To investigate the efficacy and safety of preoperative side branch embolization or intraoperative sac embolization for preventing type II endoleaks after endovascular aneurysm repair (EVAR). Materials and Methods: A systematic literature search of MEDLINE and EMBASE was performed to identify studies that evaluated the outcomes of sac embolization vs no embolization or side branch embolization vs no embolization in patients who received EVAR. Among the 904 studies screened, 17 studies with 2084 participants were included in this review. Outcome measures included the type II endoleak rate, the reintervention rate for type II endoleaks, the incidence of types I/III endoleaks, and the rate of complications. Fixed (no heterogeneity) or random effects models were constructed for each outcome; the results are presented as the odds ratio (OR) with 95% confidence interval (CI). Results: The sac embolization group had significantly lower type II endoleak (OR 0.21, 95% CI 0.13 to 0.34, p<0.001) and reintervention (OR 0.15, 95% CI 0.07 to 0.33, p<0.001) rates than the no embolization group. No significant differences between the 2 groups were found for the type I/III endoleak rate (OR 0.57, 95% CI 0.23 to 1.37, p=0.21) or complication rate (OR 1.22, 95% CI 0.32 to 4.70, p=0.77). Compared with no embolization, side branch embolization was also associated with a decrease in type II endoleak (OR 0.35, 95% CI 0.21 to 0.60, p<0.001) and reinterventions (OR 0.10, 95% CI 0.04 to 0.27, p<0.001). One severe procedure-related complication (fatal colon ischemia) was reported in the side branch embolization group. Conclusion: Sac embolization and side branch embolization are safe and effective in preventing type II endoleaks. Further randomized trials are needed to directly compare the clinical outcomes of these procedures.
引用
- Li Q, Hou P. Sac Embolization and Side Branch Embolization for Preventing Type II Endoleaks After Endovascular Aneurysm Repair: A Meta-analysis. J Endovasc Ther. 2019. PMID: 31566053. doi:10.1177/1526602819878411
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。